|2.||Leiomyoma (Uterine Fibroids)
|5.||Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
|1.||Schatz, Frederick: 9 articles (03/2015 - 09/2002)|
|2.||Learman, Lee A: 9 articles (07/2013 - 07/2003)|
|3.||Lockwood, Charles J: 8 articles (03/2015 - 09/2002)|
|4.||Washington, A Eugene: 8 articles (07/2013 - 07/2003)|
|5.||Kuppermann, Miriam: 7 articles (07/2013 - 02/2004)|
|6.||Krikun, Graciela: 7 articles (03/2011 - 09/2002)|
|7.||Taneepanichskul, Surasak: 7 articles (04/2009 - 02/2003)|
|8.||Vittinghoff, Eric: 7 articles (02/2006 - 09/2003)|
|9.||Summitt, Robert L: 7 articles (02/2006 - 07/2003)|
|10.||Varner, R Edward: 7 articles (02/2006 - 07/2003)|
|1.||Levonorgestrel (Plan B)FDA LinkGeneric
10/01/2000 - "Abnormal uterine bleeding after Norplant administration is primarily responsible for the high discontinuation rate of this safe and effective long-acting implantable progestin-only contraceptive agent. "
05/01/2015 - "A clinical study assessing the efficacy of a new variant of the levonorgestrel intrauterine system for abnormal uterine bleeding."
01/01/2015 - "To study the efficacy of levonorgestrel intrauterine system (LNG-IUS; Mirena) in conservative management of abnormal uterine bleeding (AUB). "
01/01/2013 - "To determine the efficacy of levonorgestrel intrauterine system (LNG IUS) in treatment of abnormal uterine bleeding (AUB) in women over 35 years and to determine satisfaction of users of LNG IUS in case of AUB. "
05/01/2015 - "To evaluate the efficacy and safety of a new variant of the levonorgestrel-intrauterine system (LNG-IUS)-Emily-for the treatment of abnormal uterine bleeding (AUB). "
|2.||Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/01/2012 - "This study was designed to describe the current practice for managing menstrual issues, that is, menstrual suppression and uterine bleeding, in pediatric BMT patients and to better understand health care providers' practices in the use of gonadotropin-releasing hormone agonists (GnRHa). "
08/01/2015 - "Female patients who initiated GnRH-a treatment 3-5 days postoperatively experienced less uterine bleeding during the first cycle of treatment."
02/01/1997 - "To assess the relationship of menstrual timing of administration of gonadotropin-releasing hormone (GnRH) agonist on the effectiveness of endometrial thinning and unwanted uterine bleeding. "
09/01/1993 - "Treatment of abnormal uterine bleeding with gonadotropin-releasing hormone analogues."
12/01/1986 - "Intermittent LHRH agonist administration for 21 days avoided constant down-regulation of the pituitary-ovarian axis and allowed regular uterine bleeding. "
|3.||Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
10/01/2006 - "To compare the efficacy of multidose medroxyprogesterone acetate and a multidose monophasic combined oral contraceptive (OC) for hemodynamically stable women with nongestational, acute uterine bleeding. "
07/01/2003 - "This study was undertaken to identify the determinants of patient satisfaction with a cyclic regimen of medroxyprogesterone acetate (MPA) for abnormal uterine bleeding. "
11/01/2013 - "We compared the efficacy and safety of the aerial parts of wood botany (AWB) with those of Medroxyprogesterone acetate (MPA) in the management of abnormal uterine bleeding (AUB) due to PCOS. "
06/01/2013 - "Injection of depo-medroxyprogesterone acetate 150 mg intramuscularly combined with 3 days of oral medroxyprogesterone acetate 20 mg every 8 hours for 9 doses is an effective outpatient therapy for acute abnormal uterine bleeding."
03/24/2004 - "A multicenter, randomized controlled trial (August 1997-December 2000) of 63 premenopausal women, aged 30 to 50 years, with abnormal uterine bleeding for a median of 4 years who were dissatisfied with medical treatments, including medroxyprogesterone acetate. "
06/01/2015 - "Iron deficiency is more common in women due to uterine bleeding, which affects them throughout their fertile life. "
08/01/2014 - "Although it has been a standard procedure in dialysis-associated anemia since the early 1990s, its use is expanding to a host of conditions associated with iron deficiency, especially young women with heavy uterine bleeding and pregnancy. "
01/01/1997 - "The occurrence of uterine bleeding was antagonized by the infusion of fresh-frozen plasma and a moderate anemia was subsequently treated with iron preparations. "
10/01/1991 - " Parasitic diseases and abnormal uterine bleeding also promote iron deficiency. "
02/01/2015 - "heavy, irregular, and prolonged uterine bleeding), iron defficiency anemia, or bulk symptoms (e.g., pelvic pressure/pain, obstructive symptoms), hysterectomy is a definitive solution. "
|5.||Tranexamic Acid (AMCA)FDA Link
05/01/2012 - "We included all trials involving the efficacy of tranexamic acid for the treatment of heavy uterine bleeding. "
03/01/2006 - "The percentage of subjects whose irregular uterine bleeding stopped during week 1 after the initial treatment was significantly higher in the tranexamic acid group than those in the placebo group (64.7% vs. 35.3%, p = .015). "
04/01/1987 - "The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid."
08/01/1982 - " Because of persistence of a mild uterine bleeding, tranexamic acid was continued. "
08/01/1982 - " The insertion of the IUD was followed by persistent uterine bleeding, and for this reason she began treatment with tranexamic acid (1.5 g/daily). "
01/01/1970 - "[Controversy in the use of progestagens in the treatment of abnormal uterine bleeding]."
01/01/1965 - "[Artificial progestogens and functional uterine hemorrhages]."
10/01/2002 - "To evaluate the efficacy of hysteroscopic endometrial resection such us a surgical alternative to hysterectomy in treating abnormal uterine bleeding unresponsive to treatment with progestogens. "
11/01/2014 - "Progestogens and GnRHas are the most frequently used long-term treatments for abnormal uterine bleeding and pain symptoms. "
01/01/2012 - "Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation."
|7.||Estradiol (Estrace)FDA LinkGeneric
03/01/2007 - "Menopausal women choosing estradiol therapy, especially if obese, should anticipate uterine bleeding and the possibility of an endometrial biopsy. "
03/01/2007 - "Women receiving estradiol were more likely than those receiving placebo to have at least one episode of uterine bleeding (67% versus 11% at 3 years, respectively, P<.001). "
01/01/2001 - "Postmenopausal estradiol levels have not been detected, even in those who have no uterine bleeding. "
01/01/2001 - "Postmenopausal estradiol levels have not been detected, even in those who have no uterine bleeding. "
03/01/1999 - "The regimens that were based on the lower dose of 1 mg estradiol was associated with less uterine bleeding than were those that were based on 2 mg estradiol. "
06/01/2006 - "Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users."
06/01/2011 - "Irregular uterine bleeding with DMPA associated with increased perfusion of uterine and subendometrial blood vessels."
06/01/2011 - "Forty users of DMPA were divided into two groups: one group included 20 users with irregular uterine bleeding and the second group included 20 amenorrheic users. "
06/01/2011 - "Transvaginal Doppler sonography for evaluation of irregular uterine bleeding with DMPA."
10/01/2002 - "There was no difference in the frequency of DMPA discontinuation primarily for abnormal uterine bleeding between groups (relative risk ratio = 0.95, 95%CI 0.40-2.23). "
|9.||Leuprolide (Lupron)FDA LinkGeneric
04/01/1998 - "Leuprorelin is highly effective in preventing uterine bleeding in premenopausal women undergoing stem cell transplantation and has an excellent toxicity profile and virtually no interface with hemostatic balance and hepatic function. "
10/01/2014 - "(II-1A) 5. Leuprolide acetate or combined hormonal contraception should be considered highly effective in preventing abnormal uterine bleeding when initiated prior to cancer treatment in premenopausal women at risk for thrombocytopenia. "
09/01/1995 - "An unsuspected primary cervical lymphoma thought to be a cervical fibroid decreased in size dramatically after initiation of Leuprolide acetate prior to being correctly diagnosed during subsequent hysterectomy for uterine bleeding. "
05/28/2012 - "Furthermore, uterine bleeding was controlled significantly more rapidly for recipients of ulipristal acetate than recipients of leuprolide acetate. "
05/28/2012 - "Ulipristal acetate 5 mg/day was more effective than placebo and was shown to be noninferior to intramuscular leuprolide acetate 3.75 mg once monthly in controlling uterine bleeding. "
12/01/2009 - "Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial."
01/01/2010 - "Ferric carboxymaltose (FCM, Ferinject) was effective and well tolerated in the treatment of iron-deficiency anemia (IDA) in nine, Phase III, randomized, controlled, multicenter trials in a diverse range of indications, including patients with inflammatory bowel disease (IBD), post-partum anemia (PPA) or abnormal uterine bleeding (AUB), chronic heart failure (CHF), non-dialysis-dependent chronic kidney disease (CKD) and those undergoing hemodialysis (HD). "
12/01/2009 - "The objective was to evaluate efficacy and safety of rapid, large-dose intravenous (IV) administration of ferric carboxymaltose compared to oral iron in correcting iron deficiency anemia due to heavy uterine bleeding. "
12/01/2009 - "In patients with iron deficiency anemia due to heavy uterine bleeding, rapid IV administration of large doses of a new iron agent, ferric carboxymaltose, is more effective than oral iron therapy in correcting anemia, replenishing iron stores, and improving quality of life."
01/01/2009 - "Intravenously administered ferric carboxymaltose was effective in the treatment of iron-deficiency anaemia in several 6- to 12-week, randomized, open-label, controlled, multicentre trials in various patient populations, including those with inflammatory bowel disease, heavy uterine bleeding or postpartum iron-deficiency anaemia, and those with chronic kidney disease not undergoing or undergoing haemodialysis. "
12/01/2007 - "In women who have completed their family, hysterectomy remains the most effective treatment for excessive uterine bleeding. "
08/01/2000 - "Fifteen cycling women experienced complete remission of uterine bleeding; one underwent hysterectomy during follow-up. "
01/01/2010 - "It is often effective in tamponading uterine bleeding, thus providing an alternative to hysterectomy. "
06/01/2009 - "Transcatheter embolization is a fast, safe, and effective minimally invasive alternative to hysterectomy, when medical treatment fails to control uterine bleeding. "
07/01/2015 - "Hysteroscopic Endometrial Resection Versus Laparoscopic Supracervical Hysterectomy for Abnormal Uterine Bleeding: Long-term Follow-up of a Randomized Trial."
|2.||Endometrial Ablation Techniques
05/01/2011 - "Microwave endometrial ablation is a highly efficacious way to emergently control life-threatening uterine hemorrhage."
10/01/2015 - "Cost-effectiveness modeling studies of global endometrial ablation (GEA) for treatment of abnormal uterine bleeding (AUB) from a US perspective are lacking. "
11/01/2014 - "The objectives of the study were to compare among women who had an endometrial ablation the risks of treatment failure and subsequent gynecological procedures between women with regular and irregular heavy uterine bleeding and to determine other characteristics associated with the risk of treatment failure. "
09/01/2013 - "In present study, we are assessing the efficiency of endometrial ablation by radiofrequency (Novasure(®)) for the treatment of abnormal uterine bleeding. "
11/01/2000 - "Objective of the study is to evaluate the effectiveness of endometrial ablation in patients with persistent uterine bleeding who are unresponsive to conservative therapy. "
12/01/1995 - "Hysteroscopy is an effective method for identifying the causes of postmenopausal uterine bleeding, which is superior to curettage of uterus. "
06/01/1991 - "Hysteroscopy is superior to curettage for evaluating abnormal uterine bleeding. "
01/01/2014 - "Formerly, the gold-standard clinical investigation of postmenopausal uterine bleeding was institution-based dilation and curettage, but there now exist office-based methods for the evaluation of women with this complaint. "
09/01/2015 - "This study included 199 patients who had undergone endometrial curettage due to abnormal uterine bleeding. "
12/01/2011 - "Between September 2009 to June 2010, 48 women with abnormal uterine bleeding who need to undergone uterine curettage were asked to join the present study and informed consents were signed. "
|4.||Contraception (Birth Control)
01/01/2004 - "Studies in this area offer a promising avenue to alleviate abnormal uterine bleeding associated with this otherwise highly effective form of contraception"
03/01/1996 - "We carried out studies regarding regeneration of the endometrium, and intended to induce intrauterine adhesions as a method of treatment in cases of severe uterine bleeding and as a method of contraception."
05/01/2013 - "We searched the PubMed database for peer-reviewed articles that were published in any language from inception of the database through January 2012 and were relevant to therapeutic or prophylactic treatments for unscheduled uterine bleeding during extended or continuous combined hormonal contraception use. "
05/01/2013 - "Unscheduled uterine bleeding is common among women who choose extended or continuous combined hormonal contraception and may subsequently lead to method discontinuation. "
04/01/2012 - "Subdermal implants of etonogestrol are an effective method of contraception but have a high discontinuation rate often due to irregular uterine bleeding. "
|5.||Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/01/1999 - "We conclude that the mini-hysteroscopic system offers a simple, safe and efficient diagnostic method in the office for the investigation of abnormal uterine bleeding, to evaluate the cervix and uterine cavity in the infertile patient, for screening of endometrial changes in patients under hormone replacement therapy or anti-oestrogens as (adjuvant) treatment and, lastly, it may be very helpful for the interpretation of uncertain findings in other diagnostic techniques such as ultrasound, magnetic resonance imaging, blind biopsy or hysterosalpingography."
12/01/2003 - "This study examined the endometrial pathology in postmenopausal women who had experienced abnormal uterine bleeding, both with and without hormone replacement therapy (HRT), and who subsequently underwent outpatient hysteroscopy. "
01/01/2009 - "Age, menopausal status, hormone replacement therapy (HRT) status, abnormal uterine bleeding (AUB), number of children and information from subsequent endometrial sampling were recorded when available. "
05/01/2007 - "There were included 372 patients with postmenopausal abnormal uterine bleeding diagnosis without hormone replacement therapy. "
02/01/2006 - "Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding."